CIK: 1744425 - Address: C/O Kymera Therapeutics, Inc., 500 North Beacon Street, 4Th Floor, Watertown, MA 02472
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/2/24 19:50
12/2/24
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagEsposito PamelaMADS.d-12349.000-3-1000D
9/17/24 18:20
9/17/24
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagEsposito PamelaMADS.d-65248.280-14-1000D
9/13/23 21:02
9/11/23
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagEsposito PamelaMAOChief BuS.dm-11320.010-6-2263D
8/24/23 20:30
8/22/23
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagEsposito PamelaMAOChief BuS.d-37220.010-19-7263D
8/15/23 20:30
8/11/23
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagEsposito PamelaMAOChief BuS.d-2820.000-1-1263D
7/11/23 21:00
7/10/23
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagEsposito PamelaMAOChief BuS.d-43221.580-20-7263D
5/18/23 20:31
5/16/23
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagEsposito PamelaMAOChief BuS-10818.050-6-2263D
12/13/22 20:01
12/9/22
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagEsposito PamelaMAOChief BuS.d-37525.030-15-6229D
5/18/22 19:03
5/16/22
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagEsposito PamelaMAOChief BuS-5114.590-4-2229D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact